Darden Restaurants (DRI) Stock May See Boost from Olive Garden Pasta Pass

NEW YORK (TheStreet) -- Darden Restaurants'  (DRI) casual Italian food brand Olive Garden brought back its $100 Never Ending Pasta Pass earlier this month. 

The pass lets a customer enjoy unlimited pasta, sauces, toppings, soup or salad, breadsticks, and soft drinks from October 3 to November 20. 

Olive Garden sold out of all 21,000 passes in one second on September 15, according to the restaurant. 

Now, the passes are being sold on eBay (EBAY) for up to $4,500, noted Fox Businss' Ashley Webster on "Varney & Company" Monday morning. "What's wrong with people?," he jokingly asked. 

The promotion seems to be working for the company, Circle Squared Alternative Investments CIO Jeff Sica said on the show. 

"Good for them. This is a big successful endeavor. To me, I think if they can continue to build on this momentum, it's probably very good for the Darden chain. And to me, that style restaurant is catching a lot of traction," Sica said. 

This is the third year the company has offered this promotion. 

Shares of Darden were lower in late-morning trading on Monday. 

Separately, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

TheStreet Ratings team rates Darden Restaurants as a Buy with a ratings score of A-. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that the team rates.

You can view the full analysis from the report here: DRI

DRI Chart DRI data by YCharts

More from Markets

Nvidia Shares Tank as Analysts Cut Price Targets

Nvidia Shares Tank as Analysts Cut Price Targets

Oil, Energy Stocks, Recover After Volatile Week

Oil, Energy Stocks, Recover After Volatile Week

Flashback Friday: Nvidia Is the Ultimate Chip and Dip

Flashback Friday: Nvidia Is the Ultimate Chip and Dip

Pfizer Plans Price Hikes for 41 Drugs Next Year

Pfizer Plans Price Hikes for 41 Drugs Next Year

Dow Ends Higher on Dovish Trump Tariff Comments; Nasdaq Falls

Dow Ends Higher on Dovish Trump Tariff Comments; Nasdaq Falls